Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06886971 · ClinicalTrials.gov registry record · NA
Strategies to AchieVe Viral Suppression for Youth With HIV
A NA study of Human Immunodeficiency Virus (HIV) Infection, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 1
- Study location
NCT06886971 is a NA study of Human Immunodeficiency Virus (HIV) Infection that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 288 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06886971, a NA study of Human Immunodeficiency Virus (HIV) Infection, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 1
- Study location
Study Summary
Although there have been advances in antiretroviral treatment (ART) for HIV, adolescents and young adults living with HIV (AHIV) continue to have disparate HIV outcomes particularly viral suppression (VS), when compared to other populations likely related to multi-layered challenges (social determinants, cognitive development), system, and biomedical challenges including the reliance on oral ART as the only choice for HIV treatment. Given that approximately 1/3 of AHIV despite being in care fail to attain or sustain VS with resultant individual and public health risk, there is a need to develop real-world implementable interventions that can improve the participants virologic outcomes. The Strategies to AchieVe Viral Suppression for Youth with HIV (SAVVY) Study aims to 1) optimize personal ART choice by using the HIV-ASSIST clinical program to inform CHOICE counseling regarding an AHIV's preferred approach, including the possibility of long-acting injectable ART (LAI-ART); 2) facilitate access to the participants preferred choice through deploying a focused team to navigate barriers to attaining LAI-ART; and 3) decipher and address the patient, provider, and systemic barriers to the uptake and routinization of LAI-ART among AHIV by applying an implementation science framework and assessing cost-effectiveness providing critical data to support comprehensive approaches to optimizing ART and VS for AHIV, a key population identified in the Ending the HIV Epidemic in the United States Initiative.
Conditions Studied
Interventions
- OTHER The SAVVY intervention includes CHOICE counseling and shared decision-making regarding ART preference (informed by the evidence-based HIV-ASSIST) and facilitating LA-ART access
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2024-11-10 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06886971
The ClinicalTrials.gov registry entry for NCT06886971 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Immunodeficiency Virus (HIV) Infection appearing as the primary indexed condition, and to 1 intervention - of which The SAVVY intervention includes CHOICE counseling and shared decision-making regarding ART preference (informed by the evidence-based HIV-ASSIST) and facilitating LA-ART access is the first listed.
NCT06886971 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06886971 about?
NCT06886971 is a clinical study titled "Strategies to AchieVe Viral Suppression for Youth With HIV". Although there have been advances in antiretroviral treatment (ART) for HIV, adolescents and young adults living with HIV (AHIV) continue to have disparate HIV outcomes particularly viral suppression (VS), when compared to other populations likely related to multi-layered challenges (social determin...
What is the current status of trial NCT06886971?
This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2024-11-10. Estimated completion is 2028-07-31.
What conditions does trial NCT06886971 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus (HIV) Infection.
What interventions are being tested in trial NCT06886971?
The interventions under investigation include: The SAVVY intervention includes CHOICE counseling and shared decision-making regarding ART preference (informed by the evidence-based HIV-ASSIST) and facilitating LA-ART access (OTHER).
Who is sponsoring clinical trial NCT06886971?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06886971 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus (HIV) Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.